Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

14.46USD
16 Nov 2018
Change (% chg)

$0.32 (+2.26%)
Prev Close
$14.14
Open
$14.02
Day's High
$14.49
Day's Low
$13.69
Volume
158,645
Avg. Vol
161,491
52-wk High
$34.98
52-wk Low
$12.75

Chart for

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: --
Market Cap(Mil.): $792.65
Shares Outstanding(Mil.): 36.87
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -1.70 -- --
ROI: -26.13 -0.64 15.05
ROE: -81.04 0.08 16.62

Earnings vs. Estimates